…
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Income before tax | -119.20M | 155.80M | 108.30M | 78.90M | 84.00M |
| Net income | -119.90M | 155.90M | 84.20M | 54.20M | 84.00M |
| Selling general administrative | 13.30M | 11.70M | 13.50M | 9.90M | 3.50M |
| Gross profit | 138.00M | 126.50M | 112.00M | 103.70M | 95.20M |
| Ebit | -92.40M | 114.20M | 98.00M | 93.60M | 86.20M |
| Ebitda | -91.70M | 182.30M | 132.40M | 103.60M | 105.30M |
| Depreciation and amortization | 0.70M | 68.10M | 34.40M | 10.00M | 19.10M |
| Operating income | -92.40M | 114.20M | 132.40M | 103.60M | 86.20M |
| Other operating expenses | 26.40M | 22.80M | 22.80M | 17.90M | 16.20M |
| Interest expense | 26.80M | 26.50M | 24.10M | 24.70M | 21.30M |
| Tax provision | 0.00M | -0.10M | 0.00M | 0.00M | 0.00M |
| Interest income | 1.60M | 0.40M | 0.20M | 0.00M | 0.10M |
| Net interest income | -27.30M | -28.00M | -32.20M | -26.10M | -22.40M |
| Income tax expense | 0.70M | -0.10M | 24.10M | 24.70M | -19.10M |
| Total revenue | 150.40M | 136.90M | 120.80M | 111.50M | 102.40M |
| Total operating expenses | 14.00M | 12.40M | 14.00M | 10.10M | 9.00M |
| Cost of revenue | 12.40M | 10.40M | 8.80M | 7.80M | 7.20M |
| Total other income expense net | -26.80M | 41.60M | -24.10M | -24.70M | -2.20M |
| Net income from continuing ops | -119.20M | 155.90M | 108.30M | 78.90M | 84.00M |
| Net income applicable to common shares | - | 155.90M | 108.30M | 78.90M | 84.00M |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Total assets | 2922.60M | 3120.50M | 2557.10M | 2209.30M | 2030.10M |
| Other current assets | 2.30M | 105.10M | 42.40M | 40.00M | 16.50M |
| Total liab | 1335.10M | 1330.90M | 1026.40M | 906.90M | 750.20M |
| Total stockholder equity | 1587.50M | 1789.60M | 1530.70M | 1302.40M | 1279.90M |
| Other current liab | 30.60M | 30.10M | 25.40M | 22.80M | 56.60M |
| Common stock | 296.10M | 294.80M | 267.20M | 241.30M | 239.80M |
| Capital stock | 296.10M | 294.80M | 267.20M | 241.30M | 239.80M |
| Retained earnings | 135.30M | 345.10M | 269.20M | 234.40M | 221.50M |
| Other liab | - | 6.00M | 6.10M | 4.80M | 5.30M |
| Other assets | - | 0.60M | 0.50M | 0.50M | 0.50M |
| Cash | 118.00M | 243.50M | 46.60M | 18.50M | 16.50M |
| Total current liabilities | 77.80M | 75.10M | 66.20M | 66.10M | 69.80M |
| Net debt | 1134.60M | 1006.40M | 907.60M | 828.60M | 669.60M |
| Short term debt | 0.40M | 0.10M | 0.10M | 11.10M | 11.00M |
| Short long term debt | - | - | 0.00M | 11.00M | 11.00M |
| Short long term debt total | 1252.60M | 1249.90M | 954.20M | 847.10M | 686.10M |
| Other stockholder equity | 1156.10M | 1149.70M | 994.30M | 826.70M | 819.40M |
| Property plant equipment | - | 2767.60M | 2467.20M | 2150.30M | 1979.00M |
| Total current assets | 151.50M | 348.50M | 88.70M | 58.30M | 50.60M |
| Net tangible assets | - | 1789.60M | 1530.70M | 1302.40M | 1279.90M |
| Net receivables | 33.10M | 27.20M | 26.00M | 18.00M | 10.90M |
| Long term debt | 1246.40M | 1244.40M | 948.70M | 830.50M | 672.30M |
| Inventory | - | - | - | - | 17.60M |
| Accounts payable | 46.80M | 44.90M | 40.70M | 32.20M | 2.20M |
| Accumulated other comprehensive income | - | - | - | -0.90M | -0.80M |
| Common stock total equity | - | - | 267.20M | 241.30M | 239.80M |
| Non currrent assets other | 2770.20M | 2770.90M | 2467.60M | 2150.30M | 1978.80M |
| Non current assets total | 2771.10M | 2772.00M | 2468.40M | 2151.00M | 1979.50M |
| Capital lease obligations | 6.20M | 5.50M | 5.50M | 5.60M | 2.80M |
| Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
| Investments | -130.40M | -3.50M | -0.70M | -0.20M | -0.20M |
| Change to liabilities | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total cashflows from investing activities | - | -293.90M | -267.50M | -166.20M | -224.20M |
| Net borrowings | - | 295.90M | 108.10M | 157.00M | 198.40M |
| Total cash from financing activities | -89.20M | 396.20M | 218.20M | 100.10M | 140.90M |
| Change to operating activities | 1.20M | 8.40M | 9.50M | 3.90M | 8.70M |
| Net income | -119.90M | 155.90M | 108.30M | 78.90M | 84.00M |
| Change in cash | -125.50M | 196.90M | 28.10M | 0.20M | -10.40M |
| Begin period cash flow | 243.50M | 46.60M | 18.50M | 18.30M | 28.70M |
| End period cash flow | 118.00M | 243.50M | 46.60M | 18.50M | 18.30M |
| Total cash from operating activities | -119.90M | 94.60M | 77.40M | 66.30M | 72.90M |
| Issuance of capital stock | 0.00M | 182.60M | 186.00M | - | 0.00M |
| Depreciation | 0.20M | 0.20M | 0.10M | 0.10M | 0.20M |
| Dividends paid | 88.90M | 75.40M | 61.90M | 56.60M | 55.00M |
| Change to account receivables | -4.40M | -0.90M | -5.20M | -5.80M | -0.80M |
| Sale purchase of stock | - | - | 290.50M | - | - |
| Other cashflows from financing activities | -0.30M | 309.00M | -6.40M | 156.70M | 295.90M |
| Change to netincome | 214.20M | -70.90M | -36.90M | -12.20M | -20.40M |
| Capital expenditures | 57.90M | 63.70M | 57.60M | 53.70M | 203.00M |
| Other non cash items | 119.90M | -155.90M | -108.30M | -78.90M | -84.00M |
| Free cash flow | -177.80M | -63.70M | -57.60M | -53.70M | -203.00M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PHP Primary Health Properties |
0.85 0.92% |
93.05 | 13.53 | 12.52 | 9.49 | 0.94 | 25.47 | - |
| THRL Target Healthcare REIT Ltd |
1.40 1.20% |
117.80 | 8.09 | 15.72 | 8.75 | 0.89 | 10.23 | 26.25 |
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
| Name | Title | Year Born |
|---|---|---|
| Mr. Jonathan Stewart Murphy ACA, MBA | CEO & Exec. Director | 1972 |
| Ms. Jayne Marie Cottam | CFO & Exec. Director | 1974 |
| Ms. Amanda Roddy | Sr. Investment Mang. | NA |
| Ms. Joanne Cullen | Sr. Management Accountant | NA |
| Mr. David Purcell | Head of Investor Relations | NA |
| Ms. Orla Ball | Head of Legal & Company Sec. | NA |
| Ms. Debbie Chalcraft | Group Compliance Mang. | NA |
| Ms. Francesca Harris | Marketing Mang. | NA |
| Mr. Patrick Lowther | Head of Strategy & Markets | NA |
| Mr. Simon Oborn | Head of Property Management & Investment | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.